For the first time, scientists have demonstrated that a component of cannabis reduces seizures in children with a rare form of epilepsy, marking a significant step in efforts to use marijuana and its derivatives to treat serious medical conditions. The company that sponsored the Phase 3 trial, GW Pharmaceuticals, had already announced some of the results,…